Aptevo Therapeutics Inc. — Form 8-K
Filed August 21, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 22/100
What the filing says
The 8-K filing dated 2026-08-21 reports Item 5.07 (Submission of Matters to a Vote of Security Holders), indicating a shareholder vote occurred. However, the actual text of the matters voted upon, voting results, share counts, vote percentages, and specific resolutions are not disclosed in this filing excerpt. Without access to the full document content, no concrete details about the vote can be stated.
Why this rating
Routine shareholder vote reporting. Without details on vote outcome or material matters, cannot assess business impact relative to $9.8M market cap.
Extracted items
See more from August 21, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.